Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Abeona Therapeutics' BLA Resubmission for Pz-Cel in RDEB Accepted by FDA, PDUFA Date Set for April 29, 2025 Quiver Quantitative, Inc. - Thu Nov 14, 5:04PM CST

FDA accepted Abeona's BLA resubmission for pz-cel, setting a target action date of April 29, 2025.Quiver AI SummaryAbeona Therapeutics Inc. announced that the FDA has accepted its resubmission of the Biologics...

ABEO : 6.03 (+1.52%)
Abeona Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 14, 6:42AM CST

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 6.03 (+1.52%)
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates GlobeNewswire - Thu Nov 14, 6:30AM CST

ABEO : 6.03 (+1.52%)
Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire - Tue Nov 12, 6:30AM CST

ABEO : 6.03 (+1.52%)
Abeona Therapeutics® Announces Participation in November Investor Conferences GlobeNewswire - Mon Nov 4, 6:30AM CST

ABEO : 6.03 (+1.52%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Nov 1, 6:30AM CDT

ABEO : 6.03 (+1.52%)
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration GlobeNewswire - Tue Oct 29, 6:30AM CDT

ABEO : 6.03 (+1.52%)
Abeona Therapeutics: Q2 Earnings Snapshot AP - Mon Aug 12, 6:37AM CDT

Abeona Therapeutics: Q2 Earnings Snapshot

ABEO : 6.03 (+1.52%)
Abeona Therapeutics: Q1 Earnings Snapshot AP - Wed May 15, 6:43AM CDT

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 6.03 (+1.52%)
Abeona Therapeutics: Q3 Earnings Snapshot AP - Mon Nov 13, 2023

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 6.03 (+1.52%)

Barchart Exclusives

This Dividend Stock Yielding 5% Hasn't Made Money for Buffett, But Could It Work for You? Barchart - Tue Nov 26, 6:30PM CST
Kraft-Heinz has not made money for Warren Buffett for almost a decade, since the merged entity started trading. Should you bet on the stock for its 5% dividend yield? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot